T2ND34:BVMF
Tandem Diabetes Care Inc
R$7.81
0.00%
(0.00) 1D
Aug 14, 4:56:00 PM GMT-3 · BRL
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for T2ND34...
Open
R$8.03
High
R$8.03
Low
R$7.81
Mkt. cap
1.58B
Avg. vol.
373.00
Volume
131.00
52-wk high
R$9.93
52-wk low
R$3.76
Shares outstanding
69.58M
No. of employees
2K
Open
R$8.03
High
R$8.03
Low
R$7.81
Mkt. cap
1.58B
Avg. vol.
373.00
Volume
131.00
52-wk high
R$9.93
52-wk low
R$3.76
Shares outstanding
69.58M
No. of employees
2K
News stories
From web sources and news partners
MarketBeat
·
13 hours ago
Tandem Diabetes Care (NASDAQ:TNDM) Shares Cross Above 200-Day Moving Average - Time to Sell?
StockStory
·
2 days ago
5 Must-Read Analyst Questions From Tandem Diabetes’s Q2 Earnings Call
TradingView
·
3 days ago
TNDM Q2 Loss Narrower Than Expected, Revenues Miss, Stock Up
Profile
Tandem Diabetes Care, Inc. is an American medical-device company that develops and markets insulin pumps, automated insulin delivery systems and diabetes-management software. Headquartered in San Diego, California, its principal pump platforms are the t:slim X2 and Tandem Mobi, both of which use the company's Control-IQ+ software with compatible continuous glucose monitors.
Tandem was founded in 2006 and introduced its first pump, the touchscreen t:slim, in 2012. The company became publicly traded on the Nasdaq in 2013. By the end of 2025 it reported an in-warranty user base of nearly 500,000 people in more than 25 countries and annual sales of $1.015 billion. Wikipedia
About Tandem Diabetes Care Inc
CEOJohn Sheridan
Employees2.5K
FoundedJan 2006
Headquarters-
SectorMedical device
Websitetandemdiabetes.com
AI content may include mistakes. Learn more